BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9221127)

  • 1. [The treatment of Hodgkin's disease by taking into account individual sensitivity to antitumor preparations].
    Ponomareva OV; Kindzel'skiĭ LP
    Lik Sprava; 1997; (1):103-6. PubMed ID: 9221127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The treatment of non-Hodgkin's lymphomas taking into account individual sensitivity to the chemical preparations].
    Kindzel'skiĭ LP; Sivkovich SA; Ponomareva OV
    Lik Sprava; 1996; (3-4):104-7. PubMed ID: 9035839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lyposomal form of doxorubicin hydrochloride lypodox in the treatment of lymphogranulomatosis and non-Hodgkin's lymphomas].
    Ponamareva OV; Kindzel'skiĭ LP; Kulik GI
    Lik Sprava; 2001; (1):112-7. PubMed ID: 15311711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alternating noncross-resistant polychemotherapy to improve the results of the treatment of Hodgkin's disease].
    Armata J
    Pol Tyg Lek; 1986 Oct; 41(43):1389-91. PubMed ID: 3547364
    [No Abstract]   [Full Text] [Related]  

  • 5. Results of treatment in 273 patients with Hodgkin's disease from 1971 to 1980 in comparison with results of treatment in 240 patients from 1951 to 1970.
    Kardaszewicz S; Rozak-Lesiak K; Rusinowska Z; Grzesiak A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1985; 112(6):957-63. PubMed ID: 2419227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Management of Hodgkin's disease after failure of preliminary combined treatments].
    Balwierz W; Armata J; Strzeszyński J
    Pol Tyg Lek; 1988 Mar; 43(11):347-50. PubMed ID: 3412970
    [No Abstract]   [Full Text] [Related]  

  • 7. [Comparative evaluation of subtotal irradiation and polychemotherapy in the treatment of patients with lymphogranulomatosis].
    Shust VF
    Vestn Rentgenol Radiol; 1994; (4):18-21. PubMed ID: 7785193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
    Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etoposide, carmustine, bleomycin, and methotrexate with leucovorin rescue as re-treatment for unfavorable non-Hodgkin's lymphoma.
    Helms SR; Oblon DJ; Braylan RC; Weiner RS
    Cancer Treat Rep; 1985; 69(7-8):783-6. PubMed ID: 2410118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [13 years' experience with the combined treatment of lymphogranulomatosis].
    Fokina NT
    Ter Arkh; 1988; 60(5):111-8. PubMed ID: 3175920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of advanced, resistant Hodgkin's disease and non-Hodgkin's lymphoma: a phase II study.
    Williams SF; Ultmann JE; Gaynor E; Watson S
    Cancer Treat Rep; 1986 Aug; 70(8):1033-4. PubMed ID: 2425964
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cardiogenic shock during polychemotherapy in a patient with Hodgkin's disease].
    Drzewoski J; Chojnowski K; Olszańska-Skorek T; Krykowski E
    Kardiol Pol; 1986; 29(8):555-9. PubMed ID: 2435945
    [No Abstract]   [Full Text] [Related]  

  • 13. MOPP/ABV/CAD chemotherapy with and without recombinant human granulocyte-macrophage colony stimulating factor in untreated, unfavorable prognosis Hodgkin's disease.
    Riccardi A; Gobbi P; Danova M; Giordano M; Pieresca C; Bertoloni D; Brugnatelli S; Ascari E
    Haematologica; 1993; 78(1):44-8. PubMed ID: 7684012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mopp chemotherapy in the treatment of stage IV Hodgkin's disease.
    Fiacchini M; Lauria F; Mazza P; Cantore M; Gherlinzoni F; Tura S
    Haematologica; 1985; 70(2):148-54. PubMed ID: 3924778
    [No Abstract]   [Full Text] [Related]  

  • 15. Preparation for marrow transplantation in Hodgkin's and non-Hodgkin's lymphoma using Bu/CY.
    Avalos BR; Klein JL; Kapoor N; Tutschka PJ; Klein JP; Copelan EA
    Bone Marrow Transplant; 1993 Aug; 12(2):133-8. PubMed ID: 8401359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of advanced lymphogranulomatosis. Results of MOPP/COPP treatment at the West German Tumor Center, Essen].
    Höffken K; Ippisch A; Pfeiffer R; Becher R; Seeber S; Schmidt CG
    Dtsch Med Wochenschr; 1985 Apr; 110(16):618-23. PubMed ID: 3838719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Protection of reproduction function in women with Hodgkin's disease in the course of polychemotherapy].
    Ignashina EV; Rasstrigin NA; Margolin OV; Pivnik AV; Shilin DE
    Ter Arkh; 1999; 71(10):29-32. PubMed ID: 10612170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of cancer polychemotherapy on gonadal function in Hodgkin's disease in adult men.
    Rao SV; Murugesan K; Vij U; Sarin R; Kapur BM
    Indian J Med Res; 1988 Jan; 87():37-41. PubMed ID: 3360481
    [No Abstract]   [Full Text] [Related]  

  • 19. [Long-term follow-up of Hodgkin's disease and unfavorable type of non-Hodgkin's lymphoma].
    Sampi K; Maseki N; Sakurai M; Hattori M
    Rinsho Ketsueki; 1988 Feb; 29(2):144-8. PubMed ID: 3385941
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of chemotherapy with C-MOPP in Hodgkin's disease in stages III B and IV B].
    Larraín C; Cuchacovich M; Conte G
    Rev Med Chil; 1987 Sep; 115(9):842-6. PubMed ID: 3506277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.